Oncolytics Biotech
ONCY
#10283
Rank
A$72 M
Marketcap
A$0.53
Share price
-10.37%
Change (1 day)
-65.84%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2026 (TTM): -A$56.44 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$44.22 Million a decrease over its 2024 earnings that were of -A$36.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$56.44 Million27.62%
2025 -A$44.22 Million20.47%
2024 -A$36.71 Million-5.22%
2023 -A$38.73 Million24.73%
2022 -A$31.05 Million-1.09%
2021 -A$31.39 Million5.72%
2020 -A$29.69 Million25.24%
2019 -A$23.71 Million28.77%
2018 -A$18.41 Million1.15%
2017 -A$18.21 Million5.2%
2016 -A$17.31 Million9.85%
2015 -A$15.75 Million-36.67%
2014 -A$24.87 Million-26.64%
2013 -A$33.9 Million-38.4%
2012 -A$55.03 Million27%
2011 -A$43.34 Million44.32%
2010 -A$30.03 Million35.97%
2009 -A$22.09 Million-3.27%
2008 -A$22.83 Million-10.71%
2007 -A$25.57 Million28.33%
2006 -A$19.93 Million40.52%
2005 -A$14.18 Million-13.75%
2004 -A$16.44 Million115.72%
2003 -A$7.62 Million16.58%
2002 -A$6.54 Million-4.4%
2001 -A$6.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$52.52 B-90,985.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.12 B-29,721.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.16 Billion 1,899.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$8.29 Million-85.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.84 B-3,299.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$43.88 Million-24.09%๐Ÿ‡บ๐Ÿ‡ธ USA